Search Filters:

The items contained in the list are being used to filter the search results. Click them to remove them from the search filter.
Displaying 121 - 140 of 950
PIPS Search Results
PIP Number Active Substance Conditions / Indications Invented Name Therapeutic area Decision Type Compliance Check Compliance outcome Date Published Sort ascending
MHRA-100439-PIP01-22-M01 (update)
  • Asundexian
  • Prevention of arterial thromboembolism
  • Not available at present
  • Cardiovascular Diseases
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-100253-PIP01-21-M02 (update)
  • Zuranolone
  • Treatment of postpartum depression
  • Zurzuvae
  • Psychiatry
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-100145-PIP01-21-M02 (update)
  • BRIGATINIB
  • Treatment of non-small cell lung cancer (NSCLC)
  • Treatment of anaplastic large cell lymphoma (ALCL)
  • Treatment of Inflammatory myofibroblastic tumours
  • Oncology
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-100578-PIP01-22-M01 (update)
  • SEMAGLUTIDE
  • Cagrilintide
  • Treatment of obesity
  • Endocrinology-Gynaecology-Fertility-metabolism
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-101908-PIP01-25-M01 (update)
  • MOSUNETUZUMAB
  • Treatment of mature B-cell neoplasms
  • Lunsumio
  • Haematology-Hemostaseology
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-101447-PIP01-24-M02 (update)
  • DIFELIKEFALIN ACETATE
  • Treatment of chronic kidney disease associated pruritus.
  • Kapruvia
  • Kapruvia
  • Other: Nephrology
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-100443-PIP01-22-M05 (update)
  • BARICITINIB
  • Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, ankylosing spondylarthritis, psoriatic arthritis and juvenile idiopathic arthritis)
  • Olumiant
  • Immunology -Rheumatology-Transplantation
PM: decision on the application for modification of an agreed paediatric investigation plan. Yes
MHRA-100349-PIP01-21-M03 (update)
  • Rezafungin acetate
  • Treatment of invasive candidiasis
  • Rezzayo
  • Rezzayo
  • Infectious diseases
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-101916-PIP01-25
  • PF-07248144
  • Treatment of breast cancer
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101909-PIP01-25
  • 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one
  • Treatment of prostate malignant neoplasms
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-100462-PIP01-22-M03 (update)
  • FENFLURAMINE HYDROCHLORIDE
  • Treatment of Dravet syndrome.
  • Fintepla
  • Fintepla
  • Fintepla
  • Fintepla
  • Fintepla
  • Neurology
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-101879-PIP01-25-M01 (update)
  • BECLOMETASONE DIPROPIONATE
  • FORMOTEROL FUMARATE DIHYDRATE
  • GLYCOPYRRONIUM BROMIDE
  • Treatment of asthma
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Trimbow
  • Pneumology - Allergology
PM: decision on the application for modification of an agreed paediatric investigation plan. Yes
MHRA-101159-PIP02-25
  • Sacituzumab Tirumotecan
  • Treatment of urothelial carcinoma
  • sac-TMT (佳泰莱®)
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101984-PIP01-25
  • obicetrapib
  • EZETIMIBE
  • Treatment of elevated cholesterol
  • Cardiovascular Diseases
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101781-PIP01-25
  • pozelimab
  • Treatment of paroxysmal nocturnal haemoglobinuria
  • Veopoz
  • Haematology-Hemostaseology
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) No
MHRA-101782-PIP01-25
  • cemdisiran sodium
  • Treatment of paroxysmal nocturnal haemoglobinuria
  • Haematology-Hemostaseology
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) No
MHRA-101471-PIP01-24
  • Respiratory syncytial virus, prefusion F protein, virus-like particle; Human metapneumovirus, prefusion F protein, virus-like particle
  • IVX-A12
  • Prevention of lower respiratory tract disease caused by respiratory syncytial virus
  • Prevention of lower respiratory tract disease caused by human metapneumovirus
  • Not available
  • Vaccines
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) No
MHRA-100099-PIP01-21-M05 (update)
  • BRIVARACETAM
  • Treatment of paediatric epilepsy syndromes
  • Treatment of neonatal seizures
  • Briviact
  • Neurology
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-101995-PIP01-25-M01 (update)
  • ISOFLURANE
  • Sedation of mechanically ventilated patients
  • Sedaconda and associated names
  • Other: Sedation
PM: decision on the application for modification of an agreed paediatric investigation plan. Yes Full Compliance Check Granted
MHRA-100447-PIP01-22-M03 (update)
  • Tirzepatide
  • Treatment of Type 2 diabetes mellitus.
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro, Zepbound
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro
  • Mounjaro, Zepbound
  • Endocrinology-Gynaecology-Fertility-metabolism
PM: decision on the application for modification of an agreed paediatric investigation plan. Yes Full Compliance Check Granted